Alnylam Pharmaceuticals, Inc.

FIRST TRUST ADVISORS LP ALNY

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

256,954

Value ($000)

102,178

Weight

0.1%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	102,178	0.1%	256,954	12/31/2025
2025 Q3	11/12/2025	95,935	0.1%	210,383	9/30/2025
2025 Q2	8/13/2025	82,115	0.1%	251,817	6/30/2025
2025 Q1	5/14/2025	48,728	0.0%	180,460	3/31/2025
2024 Q4	2/13/2025	77,130	0.1%	327,782	12/31/2024
2024 Q3	11/13/2024	78,541	0.1%	285,571	9/30/2024
2024 Q2	8/13/2024	58,453	0.1%	240,547	6/30/2024
2024 Q1	5/13/2024	32,486	0.0%	217,373	3/31/2024
2023 Q4	2/13/2024	58,704	0.1%	306,693	12/31/2023
2023 Q3	11/13/2023	41,351	0.0%	233,490	9/30/2023
2023 Q2	8/14/2023	52,495	0.1%	276,376	6/30/2023
2023 Q1	5/15/2023	86,155	0.1%	430,087	3/31/2023
2022 Q4	2/9/2023	99,947	0.1%	420,560	12/31/2022
2022 Q3	11/14/2022	99,065	0.1%	494,932	9/30/2022
2022 Q2	8/12/2022	58,320	0.1%	399,865	6/30/2022
2022 Q1	5/13/2022	65,749	0.1%	402,652	3/31/2022
2021 Q4	2/8/2022	85,993	0.1%	507,096	12/31/2021
2021 Q3	11/15/2021	100,501	0.1%	532,286	9/30/2021
2021 Q2	10/12/2021	85,764	0.1%	505,923	6/30/2021
2021 Q1	5/14/2021	61,012	0.1%	432,130	3/31/2021
2020 Q4	2/2/2021	73,124	0.1%	562,625	12/31/2020
2020 Q3	11/5/2020	105,649	0.2%	725,612	9/30/2020
2020 Q2	7/22/2020	119,905	0.2%	809,566	6/30/2020
2020 Q1	5/6/2020	92,221	0.2%	847,234	3/31/2020
2019 Q4	2/3/2020	68,896	0.1%	598,215	12/31/2019